期刊文献+

介入治疗371例冠心病并发症临床分析 被引量:1

Clinical Analysis for 371 Cases of Complication of Interposition Therapy for Coronary Heart Disease
下载PDF
导出
摘要 目的 :分析冠心病患者冠状动脉介入治疗的并发症发生率、发生原因和防治措施。方法 :应用回顾性调查的方法对在本院心内科于 2 0 0 2 .9~ 2 0 0 4 .5月完成冠心病介入治疗 371例的主要并发症进行统计分析。结果 :我科进行冠状动脉介入治疗共 371例 ;总并发症发生率5 .12 % ,冠状动脉痉挛 1.6 2 %、急性闭塞 0 .2 7%无再流 1.0 8% ,室颤 0 .2 7%、冠状动脉夹层1.35 %、支架内急性血栓形成 0 .5 4%等。结论 :随着经验的积累和介入器械的改进 ,介入治疗并发症发生率降低 ,但仍应引起介入医师的重视。 Objective: To study the complication rate 、cause of disease and prophylactico-therapeutic measure by analyzing 371 cases of interposition therapy for coronary heart disease. Methods: We counted and analyzed 371 cases of interposition therapy for coronary heart disease in our hospital from 2002.9 to 2004.5 with retrospective analysis method. Results: For these 371 cases patients, the complication rate was 5.12%, coronary spasm rate was 1.62%, acute coronary occlusion rate was 0.72%, no-reperfusion rate was 1.08%,ventricular fibrillation rate was 0.27%, coronary interlayer rate was 1.35%, acute thrombosis in stand was 0.54%. Conclusion: We should pay more attention to the complication of interposition therapy for coronary heart disease, though we had more experience on it and more advanced appliance.
出处 《张家口医学院学报》 2004年第3期20-21,共2页
关键词 介入治疗 冠心病 并发症 冠状动脉 coronary heart disease interposition therapy complication
  • 相关文献

参考文献4

  • 1Rodriguez AE, Palacios IF, Fernandez MA, et al. Time course and mechanism of early luminal diameter loss after percutaneous transluminal coronary angioplasty. Am J Cardiol, 1995, 76:1131 - 1134
  • 2Escorcia E, Hollman J. Current status of stent. Am J Cardiol, 1992, 69:687 - 691
  • 3高润霖,刘冰.经皮冠状动脉介入治疗指南[J].中华心血管病杂志,2002,30(12):707-718. 被引量:334
  • 4聂绍平 马长生 胡大一 马长生主编.冠心病介入治疗并发症的防治[A].胡大一,马长生主编.心脏病学实践2002-规范化治疗[C].北京:人民卫生出版社,2002.236-245.

共引文献333

同被引文献3

  • 1高润霖.正确应用冠状动脉内支架植入术[J].中华心血管病杂志,1996,24(5):330-331. 被引量:85
  • 2Shishehbor MH, Lauer MS, Singh IM, et al. In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culpritonly stenting [ J ] ? J Am Coll Cardiol, 2007, 49 ( 8 ) : 849-854.
  • 3Di Mario C, Mara S, Flavio A, et al. Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study [ J ] . Int J Cardiovasc Intervent, 2004, 6 (3-4) : 128-133.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部